This indicated that reduced levels of DSG2 and DSC2 in ARVD/C are not a consequence of mRNA down-regulation, but rather suggest an increased degradation or translation defect. The gene discussed is DSC2; the disease is arrhythmogenic right ventricular cardiomyopathy.